NCT02503917

Brief Summary

This study will establish the feasibility and accuracy of localising and outlining the uterus on ultrasound images using both healthy volunteer and cervical patient cohorts. This will enable us to determine whether or not ultrasound will be a good option to ensure the correct patient position prior to radiotherapy for cervical cancer patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2015

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 17, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 21, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

May 23, 2016

Status Verified

May 1, 2016

Enrollment Period

1 year

First QC Date

July 17, 2015

Last Update Submit

May 20, 2016

Conditions

Keywords

Imaging, UltrasoundImage-guided radiotherapyCancer

Outcome Measures

Primary Outcomes (2)

  • Percentage of ultrasound scans with dice similarity coefficient (DSC) of >0.90 between algorithm-derived contour and ground-truth contour

    The DSC between the ground truth contour and the algorithm derived contour will indicate the accuracy of the segmentation algorithm.

    DSC calculated at 24 time points for each healthy volunteer (3 days)

  • Coefficient of variation between of expert-drawn contours on ultrasound and expert-drawn contours on CBCT

    A small COV will indicate greater clinician/expert confidence in segmenting the uterus

    COV calculated at a minimum of 3 time points during 6 weeks that the patient is receiving radiation therapy

Secondary Outcomes (5)

  • Bland-Altman plot (healthy volunteer cohort)

    1 day

  • Uterine center of mass displacement on ultrasound (healthy volunteer cohort)

    3 days

  • Expert confidence scores for each imaging modality (ultrasound and MR) (healthy volunteer cohort)

    from data collected over 3 days

  • Bland-Altman plot (patient volunteer cohort)

    6 weeks

  • Expert confidence scores for each imaging modality (ultrasound, CT, and CBCT) (patient volunteer cohort)

    from data collected over 6 weeks

Study Arms (2)

Healthy volunteers

Healthy female adult volunteers

Cervical cancer patients

Patients receiving radiotherapy for cervical cancer at the Royal Marsden who will receive a planning CT scan and daily CBCT scanning as part of their treatment.

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

healthy volunteer cohort: Healthy female adult volunteers patient volunteer cohort: Patients receiving radiotherapy for cervical cancer who will receive a planning CT scan and daily CBCT scanning as part of their treatment.

You may qualify if:

  • healthy volunteer cohort: Healthy female adult volunteers
  • patient volunteer cohort: Patients receiving radiotherapy for cervical cancer who will receive a planning CT scan and daily CBCT scanning as part of their treatment.

You may not qualify if:

  • both cohorts: Women who have received hysterectomies and women who are pregnant at the time of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Marsden Hospital NHS Foundation Trust

Sutton, Surrey, SM2 5PT, United Kingdom

RECRUITING

MeSH Terms

Conditions

Uterine Cervical NeoplasmsNeoplasms

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Susan Lalondrelle

    Royal Marsden Hospital NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2015

First Posted

July 21, 2015

Study Start

September 1, 2015

Primary Completion

September 1, 2016

Study Completion

October 1, 2016

Last Updated

May 23, 2016

Record last verified: 2016-05

Locations